英文名稱 |
中文名稱 |
CAS號 |
操作 |
PD184161 |
5-溴-2-((2-氯-4-碘苯基)氨基)-N-(環(huán)丙基甲氧基)-3,4-二氟苯甲酰胺 |
212631-67-9 |
詳細(xì)
|
KEA1-97 |
KEA1-97 |
2138882-71-8 |
詳細(xì)
|
DI-591 |
DI-591 |
2245887-38-9 |
詳細(xì)
|
AP1867-3-(aminoethoxy) |
AP1867-3-(Methoxyethylamine) |
2127390-15-0 |
詳細(xì)
|
CA inhibitor 1 |
CA INHIBITOR 1 |
2189684-45-3 |
詳細(xì)
|
PKUMDL-LC-101-D04 |
PKUMDL-LC-101-D04 |
2143896-83-5 |
詳細(xì)
|
Eclitasertib |
ECLITASERTIB |
2125450-76-0 |
詳細(xì)
|
WM-3835 |
化合物WM-3835 |
2229025-70-9 |
詳細(xì)
|
BMS 753 |
4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid |
215307-86-1 |
詳細(xì)
|
RAD51-IN-1 |
RAD51-IN-17 |
2101739-18-6 |
詳細(xì)
|
IACS-13909 |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
詳細(xì)
|
RORγt inverse agonist 13 |
化合物RORΓT INVERSE AGONIST 13 |
2170477-75-3 |
詳細(xì)
|
Enpatoran |
化合物ENPATORAN |
2101938-42-3 |
詳細(xì)
|
STING-IN-3 |
化合物C-171 |
2244881-69-2 |
詳細(xì)
|
Enpatoran hydrochloride |
ENPATORAN HYDROCHLORIDE |
2101945-93-9 |
詳細(xì)
|
Edaglitazone |
依格列宗 |
213411-83-7 |
詳細(xì)
|
Cathepsin inhibitor 1 |
Cathepsin Inhibitor 1 |
225120-65-0 |
詳細(xì)
|
2'-O-Methylguanosine |
2'-甲氧基鳥苷 |
2140-71-8 |
詳細(xì)
|
Raf inhibitor 2 |
220904-99-4 |
220904-99-4 |
詳細(xì)
|
LTβR-IN-1 |
Compound 919278 |
2189366-77-4 |
詳細(xì)
|
2BAct |
2BAct(eIF2B activator 2BAct) |
2143542-28-1 |
詳細(xì)
|
FLT3-IN-3 |
SAN50900 |
2229050-90-0 |
詳細(xì)
|
TP-021 |
BCL6 inhibitor 8c |
2130878-25-8 |
詳細(xì)
|
BTK inhibitor 10 |
BTK inhibitor 10 |
2241732-30-7 |
詳細(xì)
|
MAGL-IN-4 |
His121 ARG57 |
2135785-20-3 |
詳細(xì)
|
IDRA 21 |
7-氯-3-甲基-3,4-二氫-2H-1,2,4-苯并噻二嗪 1,1-二氧化物 |
22503-72-6 |
詳細(xì)
|
FASN-IN-3 |
FASN inhibitor 1 |
2097262-60-5 |
詳細(xì)
|
JNJ4796 |
JNJ4796 |
2241664-16-2 |
詳細(xì)
|
EHMT2-IN-1 |
EHMT2-IN-1 |
2230849-55-3 |
詳細(xì)
|
MS4077 |
MS4077 |
2230077-10-6 |
詳細(xì)
|
BAY-6035 |
BAY-6035 |
2247890-13-5 |
詳細(xì)
|
EZH2-IN-2 |
EZH2-A€IN-A€2 |
2238821-31-1 |
詳細(xì)
|
Secnidazole-d |
7-Benzofurancarboxylic acid, 6-fluoro-, ethyl ester |
2114651-20-4 |
詳細(xì)
|
Pirtobrutinib |
LOXO-305 |
2101700-15-4 |
詳細(xì)
|
Vociprotafib |
RMC-4630 |
2172652-48-9 |
詳細(xì)
|
HeE1-2Tyr |
化合物HEE1-2TYR |
2245195-67-7 |
詳細(xì)
|
Dynapyrazole-A |
DYNAPYRAZOLE A |
2226517-75-3 |
詳細(xì)
|
SN-008 |
化合物SN-008 |
2249106-01-0 |
詳細(xì)
|
Fanotaprim |
化合物FANOTAPRIM |
2120282-75-7 |
詳細(xì)
|
Aminopurvalanol A |
AMINOPURVALANOL A |
220792-57-4 |
詳細(xì)
|
α5IA |
3-(5-甲基-3-異噁唑基)-6-[(1-甲基-1H-1,2,3-三氮唑-4-基)甲氧基][1,2,4]三氮唑并[3,4-A]酞嗪 |
215874-86-5 |
詳細(xì)
|
ZL0454 |
ZL0454 |
2229042-77-5 |
詳細(xì)
|
AP1867-2-(carboxymethoxy) |
FKBP12 LIGAND |
2230613-03-1 |
詳細(xì)
|
Lisaftoclax |
Bcl-2/Bcl-xl inhibitor 1 |
2180923-05-9 |
詳細(xì)
|
(Rac)-X77 |
化合物 CPD77 |
2144491-78-9 |
詳細(xì)
|
WEE1-IN-5 |
化合物DEBIO-0123 |
2243882-74-6 |
詳細(xì)
|
BMS-986299 |
BMS986299 |
2242952-69-6 |
詳細(xì)
|
CMPD-39 |
化合物USP30 INHIBITOR 18 |
2242582-40-5 |
詳細(xì)
|
MERS-CoV-IN-1 |
化合物MERS-COV-IN-1 |
2245697-92-9 |
詳細(xì)
|
Diprovocim |
Diprovocim |
2170867-89-5 |
詳細(xì)
|
NCT-505 |
NCT-505 |
2231079-74-4 |
詳細(xì)
|
IDH1 Inhibitor 1 |
IDH1 INHIBITOR 1 |
2234285-81-3 |
詳細(xì)
|
JH-XI-10-02 |
JH-XI-10-02 |
2209085-22-1 |
詳細(xì)
|
SU0268 |
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- |
2210228-45-6 |
詳細(xì)
|
PXS-5120A |
PXS-5120A |
2125955-70-4 |
詳細(xì)
|
VTP50469 fumarate |
化合物 T13336L |
2169919-29-1 |
詳細(xì)
|
Picroside IV |
胡黃連苷IV |
211567-04-3 |
詳細(xì)
|
XPC-6444 |
XPC-6444 |
2230144-21-3 |
詳細(xì)
|
SERCA2a activator 1 |
SERCA2a activator A |
2139330-34-8 |
詳細(xì)
|
Alloxan hydrate |
阿脲一水合物 |
2244-11-3 |
詳細(xì)
|
CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
詳細(xì)
|
INCB086550 |
INCB084550 |
2230911-59-6 |
詳細(xì)
|
BC1618 |
化合物BC1618 |
2222094-18-8 |
詳細(xì)
|
Reuterin |
羅氏菌素 |
2134-29-4 |
詳細(xì)
|
Et-29 |
化合物ET-29 |
2166487-23-4 |
詳細(xì)
|
Gly-Phe-β-naphthylamide |
(S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺 |
21438-66-4 |
詳細(xì)
|
ONO-4817 |
N-[(1S,3S)-1-[(ETHOXYMETHOXY)METHYL]-4-(HYDROXYAMINO)-3-METHYL-4-OXOBUTYL]-4-PHENOXYBENZAMIDE |
223472-31-9 |
詳細(xì)
|
Dazcapistat |
N-(4-AMINO-3,4-DIOXO-1-PHENYLBUTAN-2-YL)-4-(2-FLUOROPHENYL)-2-METHYLOXAZOLE-5-CARBOXAMIDE |
2221010-42-8 |
詳細(xì)
|
JNJ-55308942 |
JNJ-55308942
(JNJ55308942) |
2166558-11-6 |
詳細(xì)
|
ENMD-1198 |
化合物 STAFIB-2 |
2097938-74-2 |
詳細(xì)
|
TRPM8 antagonist 3 |
化合物TRPM8 ANTAGONIST 3 |
2102179-29-1 |
詳細(xì)
|
Inarigivir ammonium |
INARIGIVIR銨 |
2172788-92-8 |
詳細(xì)
|
TL13-12 |
TL13-12 |
2229037-04-9 |
詳細(xì)
|
OBI-3424 |
OBI-3424 |
2097713-68-1 |
詳細(xì)
|
ML-211 |
化合物ML-211 |
2205032-89-7 |
詳細(xì)
|
BMS-1166 hydrochloride |
BMS-1166 HCl |
2113650-05-6 |
詳細(xì)
|
AT-130 |
AT-130
(AT130) |
211364-06-6 |
詳細(xì)
|
Londamocitinib |
JAK1-IN-7 |
2241039-81-4 |
詳細(xì)
|
KDM2A/7A-IN-1 |
KDM2A/7A-IN-1 |
2169272-46-0 |
詳細(xì)
|
Safimaltib |
1H-Pyrazole-4-carboxamide, 1-(1,2-dihydro-1-oxo-5-isoquinolinyl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)-4-pyridinyl]- |
2230273-76-2 |
詳細(xì)
|
YTX-465 |
YTX-465 |
2225824-53-1 |
詳細(xì)
|
VB124 |
VB-124 |
2230186-18-0 |
詳細(xì)
|
CD73-IN-4 |
化合物CD73-IN-4 |
2216764-29-1 |
詳細(xì)
|
NCT-506 |
NCT-506 |
2231098-99-8 |
詳細(xì)
|
Bemnifosbuvir hemisulfate |
AT-527 |
2241337-84-6 |
詳細(xì)
|
Cyclic-di-GMP disodium |
CYCLIC DI-GMP SODIUM |
2222132-40-1 |
詳細(xì)
|
NHWD-870 |
化合物NHWD-870 |
2115742-03-3 |
詳細(xì)
|
NV-5138 |
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)- |
2095886-80-7 |
詳細(xì)
|
CAY10746 |
CAY10746 |
2247240-76-0 |
詳細(xì)
|
MLT-747 |
MLT-747 |
2097853-86-4 |
詳細(xì)
|
ELOVL1-IN-1 |
化合物ELOVL1-IN-1 |
2227482-41-7 |
詳細(xì)
|
Rimtuzalcap |
化合物RIMTUZALCAP |
2167246-24-2 |
詳細(xì)
|
GSK-3685032 |
GSK 3685032 |
2170137-61-6 |
詳細(xì)
|
Belotecan |
羅漢松雙黃酮A |
22136-74-9 |
詳細(xì)
|
LY392098 |
化合物 T27951 |
211311-39-6 |
詳細(xì)
|
TL13-112 |
TL13-112 |
2229037-19-6 |
詳細(xì)
|
BIRT 377 |
BIRT 377 |
213211-10-0 |
詳細(xì)
|
ZL0590 |
化合物ZL0590 |
2230496-99-6 |
詳細(xì)
|
Vepafestinib |
維利帕尼 |
2129515-96-2 |
詳細(xì)
|
Epitinib succinate |
琥珀酸EPITINIB |
2252334-12-4 |
詳細(xì)
|